Globus Medical Total Assets
Globus Medical total assets. Based on the latest financial reports, Globus Medical (GMED) holds total assets worth $5.49 Billion USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Globus Medical market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of Globus Medical (2010–2025)
Total assets of Globus Medical from 2010 to 2025. This chart illustrates how Globus Medical's total assets have evolved over time, based on quarterly financial data. See Globus Medical (GMED) stock price for real-time trading data and today's change.
Globus Medical - Asset Composition Analysis
Globus Medical Total Assets Breakdown (December 2025)
Globus Medical total assets breakdown as of December 2025. Globus Medical's total assets of $5.49 Billion consist of 40.1% current assets and 59.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 9.9% |
| Accounts Receivable | $743.66 Million | 14.0% |
| Inventory | $759.28 Million | 14.3% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $745.06 Million | 14.1% |
| Goodwill | $1.44 Billion | 27.1% |
Asset Composition Trend (2010–2025)
This chart illustrates how Globus Medical's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore how liquid is Globus Medical's working capital to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Globus Medical's current assets represent 40.1% of total assets in 2025, a decrease from 82.1% in 2010.
- Cash Position: Cash and equivalents constituted 9.9% of total assets in 2025, down from 41.9% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 41.0% of total assets, an increase from 0.0% in 2010.
- Asset Diversification: The largest asset category is goodwill at 27.1% of total assets.
Globus Medical Competitors by Total Assets
Key competitors of Globus Medical based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥916.43 Million |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
Applied BioCode
TW:6598
|
Taiwan | NT$1.03 Billion |
|
Oncosil Medical Ltd
AU:OSL
|
Australia | AU$7.13 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Cleo Diagnostics Ltd
AU:COV
|
Australia | AU$9.96 Million |
|
Radiant Innovation
TWO:3373
|
Taiwan | NT$859.52 Million |
|
MedX Health Corp
V:MDX
|
Canada | CA$1.26 Million |
Globus Medical - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.62 | 4.07 | 8.00 |
| Quick Ratio | 2.93 | 2.26 | 6.09 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $1.74 Billion | $1.31 Billion | $857.99 Million |
Globus Medical - Advanced Valuation Insights
This section examines the relationship between Globus Medical's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.34 |
| Latest Market Cap to Assets Ratio | 1.86 |
| Asset Growth Rate (YoY) | 1.0% |
| Total Assets | $5.30 Billion |
| Market Capitalization | $9.87 Billion USD |
Valuation Analysis
Above Book Valuation: The market values Globus Medical's assets above their book value (1.86x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: Globus Medical's assets grew by 1.0% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Globus Medical (2010–2025)
The table below shows the annual total assets of Globus Medical from 2010 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $5.30 Billion | +0.97% |
| 2024-12-31 | $5.25 Billion | +3.26% |
| 2023-12-31 | $5.09 Billion | +144.98% |
| 2022-12-31 | $2.08 Billion | +6.07% |
| 2021-12-31 | $1.96 Billion | +16.54% |
| 2020-12-31 | $1.68 Billion | +9.62% |
| 2019-12-31 | $1.53 Billion | +17.79% |
| 2018-12-31 | $1.30 Billion | +20.60% |
| 2017-12-31 | $1.08 Billion | +16.26% |
| 2016-12-31 | $927.64 Million | +11.21% |
| 2015-12-31 | $834.10 Million | +18.56% |
| 2014-12-31 | $703.55 Million | +24.23% |
| 2013-12-31 | $566.30 Million | +26.65% |
| 2012-12-31 | $447.13 Million | +35.75% |
| 2011-12-31 | $329.39 Million | +23.56% |
| 2010-12-31 | $266.57 Million | -- |
About Globus Medical
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting… Read more